Cargando…
Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening
The major cause of bacterial resistance to β-lactams is the production of hydrolytic β-lactamase enzymes. Nowadays, the combination of β-lactam antibiotics with β-lactamase inhibitors (BLIs) is the main strategy for overcoming such issues. Nevertheless, particularly challenging β-lactamases, such as...
Autores principales: | Garofalo, Barbara, Prati, Federica, Buonfiglio, Rosa, Coletta, Isabella, D’Atanasio, Noemi, Molteni, Angela, Carettoni, Daniele, Wanke, Valeria, Pochetti, Giorgio, Montanari, Roberta, Capelli, Davide, Milanese, Claudio, Di Giorgio, Francesco Paolo, Ombrato, Rosella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308845/ https://www.ncbi.nlm.nih.gov/pubmed/34202402 http://dx.doi.org/10.3390/ph14070612 |
Ejemplares similares
-
Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
por: D’Atanasio, Noemi, et al.
Publicado: (2020) -
Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches
por: Buonfiglio, Rosa, et al.
Publicado: (2020) -
Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity
por: Oueslati, Saoussen, et al.
Publicado: (2019) -
OXA-484, an OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamase From Escherichia coli
por: Sommer, Julian, et al.
Publicado: (2021) -
Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland
por: Zurfluh, Katrin, et al.
Publicado: (2015)